RWJBarnabas Health

Livingston, New Jersey 07039

1 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis

Studies at this site

• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis — Recruiting now
• Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab — Completed